Clinical Trial Update: A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating D-2570 for active systemic lupus erythematosus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• D-2570

Snippet

Sponsor: InventisBio Co., Ltd | Conditions: Active Systemic Lupus Erythematosus | Phase 2 | Status: RECRUITING